Inhibitor Research Hub

Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • Recombinant Mouse Macrophage Colony Stimulating Factor (M...

    2026-01-21

    Explore the multifaceted roles of Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) in macrophage survival, osteoclast biology, and the latest mechanistic insights into fibrosis. This cornerstone article delivers in-depth analysis and application strategies, setting it apart in the landscape of M-CSF research resources.

  • RG7388: Selective p53-MDM2 Inhibitor for Targeted Cancer ...

    2026-01-20

    RG7388 stands out as a next-generation, highly selective MDM2 antagonist that enables robust p53 pathway activation and targeted apoptosis in wild-type p53 tumor models. Its superior potency, compatibility with combination therapies, and proven efficacy in xenograft systems position it as a cornerstone for translational oncology research. Learn how to optimize its use, overcome common challenges, and integrate emerging biomarker insights for maximal experimental impact.

  • MLN4924 HCl Salt: Unlocking Neddylation Pathway Inhibitio...

    2026-01-20

    MLN4924 HCl salt is redefining experimental cancer biology by enabling precise disruption of the neddylation pathway through potent NEDD8-activating enzyme inhibition. Uniquely suited for workflows ranging from protein ubiquitination analysis to apoptosis induction studies, this APExBIO compound delivers reproducible, high-impact results and streamlines anticancer drug development.

453 records 31/31 page Previous First page 上5页 31